MMRN1 and cancer: Because of their fundamental structural and functional roles, characterizing ECM PPIs also holds the potential of identifying novel targets and devising matritherapies [1] for the whole spectrum of ECM‐associated clinical presentations, including syndromes caused by mutations in ECM genes, but also cancer and fibrosis.